APA (7th ed.) Citation

MZ, N., G, D., B, J., M, H., S, K., P, D., . . . S, C. (2014). PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation. The Journal of experimental medicine, 211(5), 781. https://doi.org/10.1084/jem.20131916

Chicago Style (17th ed.) Citation

MZ, Noman, Desantis G, Janji B, Hasmim M, Karray S, Dessen P, Bronte V, and Chouaib S. "PD-L1 Is a Novel Direct Target of HIF-1α, and Its Blockade Under Hypoxia Enhanced MDSC-mediated T Cell Activation." The Journal of Experimental Medicine 211, no. 5 (2014): 781. https://doi.org/10.1084/jem.20131916.

MLA (9th ed.) Citation

MZ, Noman, et al. "PD-L1 Is a Novel Direct Target of HIF-1α, and Its Blockade Under Hypoxia Enhanced MDSC-mediated T Cell Activation." The Journal of Experimental Medicine, vol. 211, no. 5, 2014, p. 781, https://doi.org/10.1084/jem.20131916.